Cyclacel Pharmaceuticals, Inc.
CYCC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,397 | -$1 | -$0 | -$3,052 |
| Dep. & Amort. | -$1 | $0 | $0 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | -$1,671 | $0 | $2 | $93 |
| Change in WC | $9,535 | -$4,694 | -$4,841 | $1,602 |
| Other Non-Cash | -$4,961 | $3,639 | $1,592 | $0 |
| Operating Cash Flow | $4,298 | -$1 | -$3 | -$1,356 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$5,313 | $1,921 | $3,646 | $1,613 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$0 | $0 | $0 |
| Other Fin. Act. | -$5,520 | -$41 | $0 | $1,612 |
| Financing Cash Flow | -$5,520 | $1,880 | $3,646 | $1,613 |
| Forex Effect | -$1 | $1 | -$86 | -$102 |
| Net Chg. in Cash | -$4,271 | $825 | $313 | $155 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,275 | $3 | $3,137 | $2,982 |
| End Cash | $4 | $4 | $3,450 | $3,137 |
| Free Cash Flow | $4,298 | -$1 | -$3 | -$1,356 |